REGENERON PHARMACEUTICALS, INC. ($REGN)
Filing Information
| Accession Number | 0001187443-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | May 4, 2026 |
| Document | View SEC Filing |
Transactions
12
Total Shares
100
Total Value
$70,523.80
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 1, 2026 | Sale | 5 | $701.76 | $3,508.80 | 17,598 | Direct | โ | View Details | |
Director | Common Stock | โ | May 1, 2026 | Sale | 15 | $702.46 | $10,536.90 | 17,583 | Direct | โ | View Details | |
Director | Common Stock | โ | May 1, 2026 | Sale | 24 | $703.46 | $16,883.04 | 17,559 | Direct | โ | View Details | |
Director | Common Stock | โ | May 1, 2026 | Sale | 15 | $704.28 | $10,564.20 | 17,544 | Direct | โ | View Details | |
Director | Common Stock | โ | May 1, 2026 | Sale | 14 | $705.56 | $9,877.84 | 17,530 | Direct | โ | View Details | |
Director | Common Stock | โ | May 1, 2026 | Sale | 7 | $706.74 | $4,947.18 | 17,523 | Direct | โ | View Details | |
Director | Common Stock | โ | May 1, 2026 | Sale | 4 | $707.40 | $2,829.60 | 17,519 | Direct | โ | View Details | |
Director | Common Stock | โ | May 1, 2026 | Sale | 6 | $709.45 | $4,256.70 | 17,513 | Direct | โ | View Details | |
Director | Common Stock | โ | May 1, 2026 | Sale | 2 | $710.87 | $1,421.74 | 17,511 | Direct | โ | View Details | |
Director | Common Stock | โ | May 1, 2026 | Sale | 5 | $711.49 | $3,557.45 | 17,506 | Direct | โ | View Details | |
Director | Common Stock | โ | May 1, 2026 | Sale | 1 | $712.09 | $712.09 | 17,505 | Direct | โ | View Details | |
Director | Common Stock | โ | May 1, 2026 | Sale | 2 | $714.13 | $1,428.26 | 17,503 | Direct | โ | View Details |